Description
Product Overview / 商品概要
Fildesin for Injection 1mg (注射用フィルデシン1mg)
Generic: Vindesine Sulfate / ビンデシン硫酸塩
Therapeutic Category: Antineoplastic Agent / 抗悪性腫瘍剤
Manufactured by: Nichi-Iko Pharmaceutical Co., Ltd. / 日医工株式会社
Composition & Specification / 組成・規格
Active Ingredient: Vindesine Sulfate 1mg per vial / 1バイアル中 ビンデシン硫酸塩 1mg
Additives: D-Mannitol 5mg, Sodium hydroxide, Sulfuric acid per vial / 1バイアル中 D-マンニトール 5mg、水酸化ナトリウム、硫酸
Appearance: Lyophilized powder for injection. White, light mass or powder. Freely soluble in water. Hygroscopic. pH 3.5–5.5 (1mg/mL aqueous solution), Osmotic pressure ratio approximately 1 (1mg/mL saline solution)
外観: 凍結乾燥注射剤。白色の軽質の塊又は粉末である。水に溶けやすい。吸湿性である。pH 3.5~5.5(1mg/mL水溶液)、浸透圧比 約1(1mg/mL生理食塩液)
Indications / 効能効果
EN: Remission of subjective and objective symptoms of the following diseases: Acute leukemia (including blast crisis of chronic myelogenous leukemia), malignant lymphoma, lung cancer, esophageal cancer
JA: 下記疾患の自覚的並びに他覚的症状の寛解:急性白血病(慢性骨髄性白血病の急性転化を含む)、悪性リンパ腫、肺癌、食道癌
Dosage and Administration / 用法用量
EN: As vindesine sulfate, the usual adult dose is 3mg (0.06mg/kg) per administration, and the usual pediatric dose is 0.07–0.1mg/kg per administration, given by intravenous injection at weekly intervals. Adjust as appropriate based on age and condition. As vindesine sulfate, the usual adult dose is 3–4.5mg (0.06–0.09mg/kg) per administration, given by intravenous injection at weekly intervals. Adjust as appropriate based on age and condition. (Preparation of injection solution) Dissolve vindesine sulfate 3mg (1 vial) or 1mg (1 vial) by adding water for injection or physiological saline at a ratio of 1mL per 1mg.
JA: 〈急性白血病、悪性リンパ腫〉ビンデシン硫酸塩として、通常成人1回3mg(0.06mg/kg)、小児1回0.07~0.1mg/kgを1週間間隔で静脈内に注射する。なお、年齢、症状により、適宜増減する。〈肺癌、食道癌〉ビンデシン硫酸塩として、通常成人1回3~4.5mg(0.06~0.09mg/kg)を1週間間隔で静脈内に注射する。なお、年齢、症状により、適宜増減する。(注射液の調製法)ビンデシン硫酸塩3mg(1バイアル)又は1mg(1バイアル)に、1mg当り1mLの割合で注射用水又は生理食塩液を加えて溶解する。
Contraindications / 禁忌
EN: 2.1 Patients with a history of serious hypersensitivity to the components of this product; 2.2 Intrathecal administration
JA: 2.1 本剤の成分に対し重篤な過敏症の既往歴のある患者、2.2 髄腔内
Regulatory Information / 規制情報
Approval No.: 16000AMY00052000
Sales Started: September 1985 / 1985年9月
Classification Code: 87424
Storage: Store at 2–8°C / 2~8℃保存
Shelf Life: 3 years / 3年
Packaging / 包装
Main Package (for sale): 1 vial / 1バイアル
Other Available Packages (by special order): 1 vial
Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.




Reviews
There are no reviews yet.